CaseyGerry Attorneys to Serve One-Year Term for Korean-American Bar Association of San Diego
SAN DIEGO – (November 25, 2013) Angela M. Jae, an associate attorney with San Diego-based CaseyGerry, was recently elected as an at-large board member of the Korean American Bar Association of San Diego (KABA-SD), established to help advance Korean American attorneys and law students in the legal profession.
Following more than 750 incidents of a rare strain of fungal meningitis and other related infections last year, the New England Compounding Center (NECC), in Framingham, Massachusetts recalled all of its products and was been stripped of its pharmacy license in late 2012.
The number of Americans taking cholesterol-lowering statin drugs could double under new guidelines released by the American College of Cardiology and the American Heart Association.
According to the new study, obesity should be treated like a disease and cholesterol-lowering statins can prevent cardiovascular disease in more Americans than previously thought.
A controversial diet supplement linked to liver damage and hepatitis has been recalled.
Earlier this week, the Food and Drug Administration announced that Dallas-based USPlabs is recalling certain OxyElite Pro sports supplement products – used for muscle building and weight loss – linked to an outbreak of liver illnesses.
By Jeremy K. Robinson, CaseyGerry — Published Daily Journal
Imagine: you are the managing partner at a law firm. One Saturday morning, you learn that the night before, one of your employees left work and later crashed into and killed an innocent driver.
SAN DIEGO (November 8, 2013) – Jason C. Evans, an associate attorney with San Diego-based CaseyGerry, has been elected to the Board of Directors of the New Lawyer Division of the San Diego County Bar Association (SDCBA).
Partner Wendy M. Behan recently published an article on multidistrict litigation in the Daily Journal. A federal legal procedure, multidistrict litigation is increasingly used to consolidate large-scale litigation for pre-trial purposes.
The FDA is recommending restrictions on Vicodin – an addictive painkiller that has grown into the most widely prescribed drug in the U.S. – and other hydrocodone combination drugs. FDA wants limits on prescribed painkillers
In an important policy shift, the U.S.
